Clinical Trials Directory

Trials / Unknown

UnknownNCT03440671

The Safety and Efficacy Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

A Multicenter, Double-Blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase 3 Clinical Trial to Compare the Efficacy and Safety Study of Hutox Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
260 (estimated)
Sponsor
Huons Co., Ltd. · Industry
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

A Phase Ⅲ Clinical Trial to Compare the Safety and Efficacy of Hutox versus Botox® in Subject with Moderate to Severe Glabellar Lines

Conditions

Interventions

TypeNameDescription
BIOLOGICALHutox InjHutox Inj(Clostridium botulinum type A)
BIOLOGICALBotox InjBotox Inj(Clostridium botulinum type A)

Timeline

Start date
2017-11-30
Primary completion
2018-10-30
Completion
2018-12-30
First posted
2018-02-22
Last updated
2018-04-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03440671. Inclusion in this directory is not an endorsement.